Zentiva
Elliot Statham is an experienced professional in business development, currently serving as the Head of Business Development & New Product Introduction at Zentiva since July 2019. Statham's role involves identifying new product opportunities, negotiating commercial agreements, and developing long-term strategic plans for the UK market. Prior to this, Statham held the position of Senior Business Development Manager at Zentiva and Business Development Manager, focusing on business growth through the identification of new opportunities and collaborative projects. Earlier experience includes a role as a Business Development Specialist at Creo Pharma, where responsibilities encompassed product forecasting and the identification of in-licensing opportunities. Elliot Statham holds a Bachelor of Arts in Business with Marketing Management from Northumbria University.
This person is not in any teams
This person is not in any offices
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.